Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development
Go back to Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development| (NASDAQ: ENVB) | Delayed: 1.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.48 | 52 Week High | $ | |||
| Open | $1.48 | 52 Week Low | $ | |||
| Day High | $1.48 | P/E | N/A | |||
| Day Low | $1.48 | EPS | $ | |||
| Volume | 650 | |||||

